MedPage Today on MSN
Year in Review: Alzheimer's Disease
News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...
New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...
12hon MSN
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...
Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...
Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...
Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...
The actor’s National Geographic documentary shows the power of memory and social connection in supporting his father’s ...
MedPage Today on MSN
Highly Anticipated Alzheimer's Trials Yield Disappointing Results for GLP-1 Drug
The biomarker improvements in the EVOKE studies are worth noting, observed Howard Fillit, MD, of the Alzheimer's Drug ...
FOX 32 Chicago on MSN
How to spot signs of Alzheimer's disease in a loved one
Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...
20hon MSN
Novo Nordisk slides as Ozempic pill fails to slow Alzheimer’s disease progression in large trials
Novo Nordisk (NVO) fell nearly 10% in U.S. premarket trading on Monday after the Danish drugmaker said a pill version of ...
In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results